The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Prevention of Torsade de Pointes in Hospital Settings
Open accessAbstract
TdP is an uncommon but potentially fatal arrhythmia that can be caused by drugs that cause selective prolongation of action potential durations in certain layers of the ventricular myocardium, which creates dispersion of repolarization and a long, distorted QT-U interval on the ECG. A summary of key points to remember is provided in Table 3. Table 3 Summary of Key Points For patients who receive QT-prolonging drugs in hospital units with continuous ECG monitoring, TdP should be avoidable if there is an awareness of individual risk factors and the ECG signs of drug-induced LQTS. Particularly important are the ECG risk factors for TdP, including marked QTc prolongation to >500 ms (with the exception of amiodarone- or verapamil-induced QT prolongation), marked QT-U prolongation and distortion after a pause, onset of ventricular ectopy and couplets, macroscopic T-wave alternans, or episodes of polymorphic ventricular tachycardia that are initiated with a short-long-short R-R cycle sequence (typically, PVC– compensatory pause–PVC). Recognition of these ECG harbingers of TdP allows for treatment with intravenous magnesium, removal of the offending agent, and correction of electrolyte abnormalities and other exacerbating factors, including the prevention of bradycardia and long pauses with temporary pacing if necessary.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram
Surawicz, B., Childers, R., Deal, B. J., & Gettes, L. S. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.013 · Cited by 2,032
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Self-citationDrug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Self-citationSCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Wang, Q., Shen, J., Splawski, I., Atkinson, D., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,686
Risk Stratification in the Long-QT Syndrome
Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022147 · Cited by 1,459
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
Approaches to Sudden Death from Coronary Heart Disease
LOWN, B., & WOLF, M. (1971) · Circulation · doi:10.1161/01.cir.44.1.130 · Cited by 1,257
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C., Møller, M., Bloch-Thomsen, P. E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
The long QT syndrome. Prospective longitudinal study of 328 families.
Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., MacCluer, J., Hall, W. J., Weitkamp, L., Vincent, G. M., & Garson, A. (1991) · Circulation · doi:10.1161/01.cir.84.3.1136 · Cited by 968
Recommendations for the Standardization and Interpretation of the Electrocardiogram
Kligfield, P., Gettes, L. S., Bailey, J. J., Childers, R., Deal, B. J., Hancock, E. W., van Herpen, G., Kors, J. A., Macfarlane, P., Mirvis, D. M., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.024 · Cited by 807
Self-citationKligfield (2007) · doi:10.1161/circulationaha.106.180200 · Cited by 802
Influence of the Genotype on the Clinical Course of the Long-QT Syndrome
Zareba, W., Moss, A. J., Schwartz, P. J., Vincent, G. M., Robinson, J. L., Priori, S. G., Benhorin, J., Locati, E. H., Towbin, J. A., Keating, M. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391404 · Cited by 754
Self-citationElectrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties
Antzelevitch, C., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Di Diego, J. M., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 675
Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes
RODEN, D. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00148.x · Cited by 667
Self-citationTerfenadine-Ketoconazole Interaction: Pharmacokinetic and Electrocardiographic Consequences
Honig, P. K. (1993) · JAMA · doi:10.1001/jama.1993.03500120051025 · Cited by 664
Mechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
Drew, B. J., Califf, R. M., Funk, M., Kaufman, E. S., Krucoff, M. W., Laks, M. M., Macfarlane, P. W., Sommargren, C., Swiryn, S., & Van Hare, G. F. (2004) · Circulation · doi:10.1161/01.cir.0000145144.56673.59 · Cited by 609
Self-citationAllelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 554
Self-citationVariant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia
Splawski, I., Timothy, K. W., Tateyama, M., Clancy, C. E., Malhotra, A., Beggs, A. H., Cappuccio, F. P., Sagnella, G. A., Kass, R. S., & Keating, M. T. (2002) · Science · doi:10.1126/science.1073569 · Cited by 523
Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 488
Self-citationNeal Kay, G., Vance J., P., Joaquin G., A., Richard W., H., & Albert L., W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463
Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P., Verheugt, F. W. A., Gersh, B. J., McCabe, C. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.724880 · Cited by 445
Yang, T., & Roden, D. M. (1996) · Circulation · doi:10.1161/01.cir.93.3.407 · Cited by 429
Self-citationTorsade de Pointes Associated with Very-High-Dose Methadone
Krantz, M. J., Lewkowiez, L., Hays, H., Woodroffe, M. A., Robertson, A. D., & Mehler, P. S. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00010 · Cited by 426
Sauer, A. J., Moss, A. J., McNitt, S., Peterson, D. R., Zareba, W., Robinson, J. L., Qi, M., Goldenberg, I., Hobbs, J. B., Ackerman, M. J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.057 · Cited by 419
Self-citation[Ventricular tachycardia with 2 variable opposing foci].
Dessertenne, F. (1966) · PubMed · Cited by 414
Viskin, S., Rosovski, U., Sands, A. J., Chen, E., Kistler, P. M., Kalman, J. M., Rodriguez Chavez, L., Iturralde Torres, P., Cruz F, F. E. S., Centurión, O. A., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.02.011 · Cited by 409
Rate-corrected QT interval: Techniques and limitations
Funck-Brentano, C., & Jaillon, P. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90035-b · Cited by 401
Thomsen, M. B., Verduyn, S. C., Stengl, M., Beekman, J. D. M., de Pater, G., van Opstal, J., Volders, P. G. A., & Vos, M. A. (2004) · Circulation · doi:10.1161/01.cir.0000145162.64183.c8 · Cited by 361
Drug‐Induced Torsades de Pointes and Implications for Drug Development
FENICHEL, R. R., MALIK, M., ANTZELEVITCH, C., SANGUINETTI, M., RODEN, D. M., PRIORI, S. G., RUSKIN, J. N., LIPICKY, R. J., CANTILENA, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 346
Self-citationQTc Interval Screening in Methadone Treatment
Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., & Haigney, M. C. P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00103 · Cited by 337
Long QT syndrome: reduced repolarization reserve and the genetic link
RODEN, D. M. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01589.x · Cited by 322
Self-citationAccurate electrocardiographic assessment of the QT interval: Teach the tangent
Postema, P. G., De Jong, J. S. S. G., Van der Bilt, I. A. C., & Wilde, A. A. M. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.03.037 · Cited by 317
Cellular mechanisms underlying the long QT syndrome
Antzelevitch, C., & Shimizu, W. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200201000-00007 · Cited by 313
Akar, F. G., Yan, G.-X., Antzelevitch, C., & Rosenbaum, D. S. (2002) · Circulation · doi:10.1161/hc1002.105231 · Cited by 302
Assessing predictors of drug-induced torsade de pointes
Belardinelli, L., Antzelevitch, C., & Vos, M. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.002 · Cited by 302
NAPOLITANO, C., SCHWARTZ, P. J., BROWN, A. M., RONCHETTI, E., BIANCHI, L., PINNAVAIA, A., ACQUARO, G., & PRIORI, S. G. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00033.x · Cited by 300
Ackerman, M. J., Tester, D. J., Jones, G. S., Will, M. L., Burrow, C. R., & Curran, M. E. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1479 · Cited by 297
Self-citationPaulussen, A. D. C., Gilissen, R. A. H. J., Armstrong, M., Doevendans, P. A., Verhasselt, P., Smeets, H. J. M., Schulze-Bahr, E., Haverkamp, W., Breithardt, G., Cohen, N., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0522-z · Cited by 280
Torsade de Pointes Due to Noncardiac Drugs: Most Patients Have Easily Identifiable Risk Factors
Zeltser, D., Justo, D., Halkin, A., Prokhorov, V., Heller, K., & Viskin, S. (2003) · Medicine · doi:10.1097/01.md.0000085057.63483.9b · Cited by 273
Hennessy, S., Bilker, W. B., Knauss, J. S., Margolis, D. J., Kimmel, S. E., Reynolds, R. F., Glasser, D. B., Morrison, M. F., & Strom, B. L. (2002) · BMJ · doi:10.1136/bmj.325.7372.1070 · Cited by 261
Genetics of acquired long QT syndrome
Roden, D. M. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25539 · Cited by 256
Self-citationThe Morphology of the QT Interval Predicts Torsade de Pointes During Acquired Bradyarrhythmias
Topilski, I., Rogowski, O., Rosso, R., Justo, D., Copperman, Y., Glikson, M., Belhassen, B., Hochenberg, M., & Viskin, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.058 · Cited by 236
Drug-induced long QT and torsade de pointes: recent advances
Kannankeril, P. J., & Roden, D. M. (2007) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32801129eb · Cited by 227
Self-citationIs Gender a Risk Factor for Adverse Drug Reactions?: The Example of Drug-Induced Long QT Syndrome
Drici, M.-D., & Cl??ment, N. (2001) · Drug Safety · doi:10.2165/00002018-200124080-00002 · Cited by 226
EBERT, S. N., LIU, X.-K., & WOOSLEY, R. L. (1998) · Journal of Women's Health · doi:10.1089/jwh.1998.7.547 · Cited by 224
Plant, L. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25618 · Cited by 215
El-Sherif, N., Chinushi, M., Caref, E. B., & Restivo, M. (1997) · Circulation · doi:10.1161/01.cir.96.12.4392 · Cited by 215
Carlsson, L., Abrahamsson, C., Andersson, B., Duker, G., & Schiller-Linhardt, G. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2186 · Cited by 213
Mason, J. W., Hondeghem, L. M., & Katzung, B. G. (1984) · Circulation Research · doi:10.1161/01.res.55.3.278 · Cited by 209
Normalization of Acquired QT Prolongation in Humans by Intravenous Potassium
Choy, A. M., Lang, C. C., Chomsky, D. M., Rayos, G. H., Wilson, J. R., & Roden, D. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2149 · Cited by 196
Self-citationCardiac Actions of Erythromycin: Influence of Female Sex
Drici, M.-D., Knollmann, B. C., Wang, W.-X., & Woosley, R. L. (1998) · JAMA · doi:10.1001/jama.280.20.1774 · Cited by 194
Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome
Wu, L., Shryock, J. C., Song, Y., Li, Y., Antzelevitch, C., & Belardinelli, L. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.066100 · Cited by 193
T wave alternans in idiopathic long QT syndrome
Zareba, W., Moss, A. J., le Cessie, S., & Hall, W. J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90653-x · Cited by 184
Self-citationEffect of Clinical Phenotype on Yield of Long QT Syndrome Genetic Testing
Tester, D. J., Will, M. L., Haglund, C. M., & Ackerman, M. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.056 · Cited by 184
Self-citationThe long QT syndrome family of cardiac ion channelopathies: A HuGE review
Modell, S. M., & Lehmann, M. H. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000204468.85308.86 · Cited by 179
Drug Block of I Kr : Model Systems and Relevance to Human Arrhythmias
Yang, T., Snyders, D., & Roden, D. M. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200111000-00010 · Cited by 171
Self-citationMurray, K. T. (1998) · Circulation · doi:10.1161/01.cir.97.5.493 · Cited by 161
von Bahr, C., Movin, G., Nordin, C., Lidén, A., Hammarlund-Udenaes, M., Hedberg, A., Ring, H., & Sjöqvist, F. (1991) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1991.22 · Cited by 158
Clinical safety profile of sotalol in patients with arrhythmias
Soyka, L. F., Wirtz, C., & Spangenberg, R. B. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90207-h · Cited by 155
Shaffer, D., Singer, S., Korvick, J. A., & Honig, P. K. (2002) · Clinical Infectious Diseases · doi:10.1086/340861 · Cited by 151
Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter
Kowey, P. R., VanderLugt, J. T., & Luderer, J. R. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00566-8 · Cited by 132
Torsade de Pointes Associated with the Use of Intravenous Haloperidol
Wilt, J. L., Minnema, A. M., Johnson, R. F., & Rosenblum, A. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00007 · Cited by 126
How Really Rare Are Rare Diseases?:
Schwartz, P. J., Priori, S. G., & Napolitano, C. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03339.x · Cited by 124
Houltz, B., Darpö, B., Edvardsson, N. G., Blomström, P., Brachmann, J., Crijns, H. J. G. M., Jensen, S. M., Svernhage, E., Vallin, H., & Swedberg, K. B. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00150.x · Cited by 122
In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugs
Bruin, M. L. D., Langendijk, P. N. J., Koopmans, R. P., Wilde, A. A. M., Leufkens, H. G. M., & Hoes, A. W. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02722.x · Cited by 120
Role of SCN5A Y1102 Polymorphism in Sudden Cardiac Death in Blacks
Burke, A., Creighton, W., Mont, E., Li, L., Hogan, S., Kutys, R., Fowler, D., & Virmani, R. (2005) · Circulation · doi:10.1161/circulationaha.104.482760 · Cited by 118
QTc Interval in the Assessment of Cardiac Risk
Elming, H., Brendorp, B., Køber, L., Sahebzadah, N., & Torp-Petersen, C. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016345412555 · Cited by 102
Nuttall, G. A., Eckerman, K. M., Jacob, K. A., Pawlaski, E. M., Wigersma, S. K., Marienau, M. E. S., Oliver, W. C., Narr, B. J., & Ackerman, M. J. (2007) · Anesthesiology · doi:10.1097/01.anes.0000281893.39781.64 · Cited by 102
Self-citationDrug Therapy For Torsade de Pointes
Banai, S., & Tzivoni, D. (1993) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1993.tb01224.x · Cited by 98
Lehtonen, A., Fodstad, H., Laitinen-Forsblom, P. J., Toivonen, L. K., KONTULA, K. K., & Swan, H. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.01.019 · Cited by 98
Amiodarone and Torsade de Pointes
Lazzara, R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-549 · Cited by 93
Drug‐induced torsades de pointes: a review of the Swedish pharmacovigilance database
Åström‐Lilja, C., Odeberg, J. M., Ekman, E., & Hägg, S. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1607 · Cited by 92
Zaręba, W. (2007) · PubMed · Cited by 90
How to correct the QT interval for the effects of heart rate in clinical studies
Davey, P. P. (2002) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(03)00008-x · Cited by 90
Effects of low potassium or magnesium concentrations on isolated cardiac tissue
Roden, D. M., & Iansmith, D. H. S. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90128-8 · Cited by 90
Self-citationHondeghem, L. M. (2006) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2006.00347.x · Cited by 89
Drug-induced torsades de pointes: The evolving role of pharmacogenetics
Fitzgerald, P., & Ackerman, M. J. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.08.007 · Cited by 88
Self-citationRoden, D. M. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.suppl_h.56 · Cited by 87
Self-citationQT lengthening and life-threatening arrhythmias associated with fexofenadine
Pinto, Y. M., Gelder, I. C. V., Heeringa, M. J., & Crijns, H. J. G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01009-0 · Cited by 78
Pedersen, H. S., Elming, H., Seibæk, M., Burchardt, H., Brendorp, B., Torp-Pedersen, C. T., & Køber, L. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.020 · Cited by 74
Citalopram overdose: Late presentation of torsades de pointes (TdP) with cardiac arrest
Tarabar, A. F., Hoffman, R. S., & Nelson, L. S. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03160963 · Cited by 72
Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors
Justo, D., Prokhorov, V., Heller, K., & Zeltser, D. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00469.x · Cited by 70
Norstrand, D. W. V., Tester, D. J., & Ackerman, M. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.012 · Cited by 69
Self-citationTorsades de Pointes Induced by Erythromycin
Gitler, B., Berger, L. S., & Buffa, S. D. (1994) · CHEST Journal · doi:10.1378/chest.105.2.368 · Cited by 64
Individual Patterns of QT/RR Relationship
Batchvarov, V. N., & Malík, M. (2002) · Cardiac Electrophysiology Review · doi:10.1023/a:1016393328485 · Cited by 62
Life‐threatening ventricular tachycardia due to liquorice‐induced hypokalaemia
Eriksson, J. W., Carlberg, B., & Hillörn, V. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00476.x · Cited by 62
Drew, B. J., & Funk, M. (2006) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2006.01.007 · Cited by 59
Self-citationWooten, J. M. (2006) · Southern Medical Journal · doi:10.1097/01.smj.0000197301.37152.b3 · Cited by 57
Frequency of high‐risk use of QT‐prolonging medications
LaPointe, N. M. A., Curtis, L. H., Chan, K. A., Kramer, J. M., Lafata, J. E., Gurwitz, J. H., Raebel, M. A., & Platt, R. G. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1155 · Cited by 55
Darbar, D., Kimbrough, J., Jawaid, A., McCray, R., Ritchie, M. D., & Roden, D. M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.066 · Cited by 55
Self-citationPinski, S. L., Eguía, L. E., & Trohman, R. G. (2002) · Pacing and Clinical Electrophysiology · doi:10.1046/j.1460-9592.2002.01612.x · Cited by 54
Mank-Seymour, A. R., Richmond, J., Wood, L. S., Reynolds, J. M., Fan, Y.-T., Warnes, G. R., Milos, P. M., & Thompson, J. F. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.08.020 · Cited by 54
Kligfield, P., Hancock, E. W., Helfenbein, E. D., Dawson, E. J., Cook, M. A., Lindauer, J. M., Zhou, S., & Xue, J. Q. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.060 · Cited by 50
Self-citationYasuda, M., Nakazato, Y., Sasaki, A., Kawano, Y., Nakazato, K., Tokano, T., & Daida, H. (2006) · Circulation Journal · doi:10.1253/circj.70.662 · Cited by 48
Torsade de pointes ventricular tachycardia a complication of disopyramide shared with quinidine
Wald, R. W., Waxman, M. B., & Colman, J. M. (1981) · Journal of Electrocardiology · doi:10.1016/s0022-0736(81)80013-1 · Cited by 47
Torsade de pointes induced by N-Acetylprocainamide
Chow, M. J., Piergies, A. A., Bowsher, D. J., Murphy, J. J., Kushner, W., Ruo, T. I., Asada, A., Talano, J. V., & Atkinson, A. J. (1984) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(84)80111-4 · Cited by 44
Hypocalcemic torsades de pointes
Akiyama, T., Batchelder, J. E., Worsman, J., Moses, H. W., & Jedlinski, M. (1989) · Journal of Electrocardiology · doi:10.1016/0022-0736(89)90026-5 · Cited by 42
Torsades de pointes induced by antibiotics
Justo, D., & Zeltser, D. (2006) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2005.12.003 · Cited by 41
Concomitant Use of Antipsychotics and Drugs That May Prolong the QT Interval
Roe, C. M., Odell, K. W., & Henderson, R. R. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00013 · Cited by 41
Singh, B. N. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90962-x · Cited by 37
An algorithm for continuous real-time QT interval monitoring
Helfenbein, E. D., Zhou, S., Lindauer, J. M., Field, D. Q., Gregg, R. E., Wang, J. J., Kresge, S. S., & Michaud, F. P. (2006) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2006.05.018 · Cited by 36
White, C. M., Xie, J., Chow, M. S. S., & Kluger, J. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.8.635.31528 · Cited by 29
Torsades de pointes: Prevention and therapy
Keren, A., & Tzivoni, D. (1991) · Cardiovascular Drugs and Therapy · doi:10.1007/bf03029778 · Cited by 28
Ciprofloxacin- and Hypocalcemia-Induced Torsade de Pointes Triggered by Hemodialysis
Daya, S. K., Gowda, R. M., & Khan, I. A. (2004) · American Journal of Therapeutics · doi:10.1097/00045391-200401000-00014 · Cited by 27
Nakasone, H., Sugama, R., Sakugawa, H., Matayoshi, R., Miyagi, T., Maeshiro, T., Yamashiro, T., Higa, F., Hokama, A., Kinjo, F., et al. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170061 · Cited by 25
Raviña, T., Raviña, P., & Gutiérrez, J. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.084 · Cited by 24
Justo, D., & Zeltser, D. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01278.x · Cited by 23
Preventing Torsades de Pointes by Careful Cardiac Monitoring in Hospital Settings
Sommargren, C. E., & Drew, B. J. (2007) · AACN Advanced Critical Care · doi:10.4037/15597768-2007-3007 · Cited by 22
Self-citationManagement of Ventricular Dysrhythmia Secondary to Trazodone Overdose
Chung, K.-J., Wang, Y.-C. L., Liu, B., & Supernaw, R. B. (2007) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.02.036 · Cited by 22
Fiset, C., Drolet, B., Hamelin, B. A., & Turgeon, J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36991-5 · Cited by 20
Dı́az-Castro, Ó., Puchol, A., Almendral, J. M., Torrecilla, E. G., Arenal, Á., & Martínez‐Sellés, M. (2004) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2003.10.003 · Cited by 19
Kawabata, M., Hirao, K., Sasaki, T., Sakurai, K., Inagaki, H., Hachiya, H., & Isobe, M. (2008) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2007.09.009 · Cited by 17
[The value of magnesium in intensive care medicine].
Lüderitz, B., & Manz, M. G. (1994) · PubMed · Cited by 8
Cited by
Panchal, A. R., Bartos, J. A., Cabañas, J. G., Donnino, M. W., Drennan, I. R., Hirsch, K. G., Kudenchuk, P. J., Kurz, M. C., Lavonas, E. J., Morley, P. T., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000916 · Cited by 2,105
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu282 · Cited by 1,656
Topjian, A. A., Raymond, T. T., Atkins, D., Chan, M., Duff, J. P., Joyner, B. L., Lasa, J. J., Lavonas, E. J., Levy, A., Mahgoub, M., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000901 · Cited by 1,258
Herrmann, J., Lenihan, D., Armenian, S., Barac, A., Blaes, A., Cardinale, D., Carver, J., Dent, S., Ky, B., Lyon, A. R., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab674 · Cited by 645
Verrier (2011) · doi:10.1016/j.jacc.2011.06.029 · Cited by 421
Metadata
- Authors
- Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 55
- Issue
- 9
- Pages
- 934-947
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1576812268
- Cited by
- 367
- References
- 117
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.